![]() ![]() ![]() Concomitant use of drugs affecting hemostasis increases the risk of bleeding, including aspirin and other antiplatelet agents, other anticoagulants, heparin, thrombolytic agents, SSRIs, SNRIs, and NSAIDs.Bleeding Risk: ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding.If ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant. An increased rate of stroke was observed during the transition from ELIQUIS to warfarin in clinical trials in atrial fibrillation patients. Increased Risk of Thrombotic Events after Premature Discontinuation: Premature discontinuation of any oral anticoagulant, including ELIQUIS, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events.Severe hypersensitivity reaction to ELIQUIS (e.g., anaphylactic reactions).If neurological compromise is noted, urgent treatment is necessary.Ĭonsider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated. Monitor patients frequently for signs and symptoms of neurological impairment. optimal timing between the administration of ELIQUIS and neuraxial procedures is not known.a history of spinal deformity or spinal surgery.a history of traumatic or repeated epidural or spinal punctures.concomitant use of other drugs that affect hemostasis, such as nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants.Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: Consider these risks when scheduling patients for spinal procedures. These hematomas may result in long-term or permanent paralysis. (B) Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture. If anticoagulation with ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant. (A) Premature discontinuation of any oral anticoagulant, including ELIQUIS ® (apixaban), increases the risk of thrombotic events. WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA Residents can print a free pre-activated card, locate participating pharmacies, and search drug pricing by visiting Those unable to obtain a card can also visit any CVS/pharmacy and ask to have their prescription processed through Florida Rx Card.SELECTED IMPORTANT SAFETY INFORMATION IMPORTANT SAFETY INFORMATION MORE IMPORTANT SAFETY INFORMATION With the rising cost of healthcare, the Florida Rx Card provides a simple solution to the high prices of prescription medications. The program is accepted at CVS/pharmacy, Walgreens, Walmart, Target, Winn Dixie and Kmart, along with over 68,000 participating pharmacies nationwide. The program is completely confidential and all cards are pre-activated, ready for use and do not expire. There are no restrictions or eligibility requirements for the program. Florida Rx Card is free for everyone and provides discounts as high as 80% on most brand and generic medications. Florida residents with insurance can also utilize the program for their non-covered medications.įlorida Rx Card works with Florida Hospital Association and Florida Academy of Physician Assistants (FAPA), as well as many hospitals and clinics to expand card distribution sites throughout the state. The program was launched in August 2007 to help uninsured and underinsured Florida residents with their prescription medication costs. Florida Rx Card is the free statewide prescription assistance program available to all Florida residents. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |